Omnicell to present its newest innovations in medication management
Category: #health  | By Mateen Dalal  | Date: 2020-01-27 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Omnicell to present its newest innovations in medication management

Omnicell, Inc., a U.S. based company that offers adherence tools for healthcare systems and pharmacies along with medication management solutions, has recently revealed that it would be presenting its medication management portfolio’s latest developments at the Arab Health Exhibition and Congress, held in Dubai.

For the record, this exhibition is renowned to be the largest gathering of trade and healthcare professionals in the MEA.

Reportedly, recent estimates say that over the span of nine years, Saudi Arabia’s healthcare spending has experienced a compound annual growth rate of 12.1% and could well off reach US$160 billion by 2030.

Evidently, Omnicell’s lineup of services takes the vision of autonomous pharmacy further. Apparently, autonomous pharmacy is a roadmap developed to enhance operational efficiencies and patient outcomes while steadily minimizing cost through a series of digital and autonomous workflows that are backed by cloud data platform.

Basically, it would help integrate solutions across three major sections, namely expert services, automation, and Intelligence.

Speaking on the move, Arthur Van Dongen, General Manager and Vice President, International, Omnicell, said that the company recognizes the cost and risk related with inefficient & manual processes. The company is determined to develop the tools and technology that could automate these practices. This would help its hospital partners attain their financial, clinical and operational outcomes.

Prior to this news, Omnicell had made headlines when it revealed that Pittsburgh’s Allegheny General Hospital, a division of Allegheny Health Network (AHN), had chosen its Central Pharmacy IV Compounding solution, a turnkey, comprehensive method for insourcing certain sterile compounding operations.

It is reported that roughly one of ten IVs aren’t trained within guidelines using manual processes, with one of the most frequent errors being contamination. This solution would address the aforementioned issue with the help of data, expertly trained pharmacy technician staff and advanced robotic technology, enabling enhanced patient safety and lowering cost of pharmacy outsourcing.

Source Credit: https://finance.yahoo.com/news/omnicell-showcases-latest-advancements-medication-040000547.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

ChatGPT’s creator OpenAI proposes regulation of AI by humans

ChatGPT’s creator OpenAI proposes regulation of AI by humans

By Mateen Dalal

OpenAI, the creator of ChatGPT, has reportedly put forward a proposal for the establishment of an international organization to regulate artificial intelligence (AI). Led by CEO Sam Altman, the company believes that AI systems developed within the ne...

Medtronic pledges USD 350 Mn to expand R&D operations in India

Medtronic pledges USD 350 Mn to expand R&D operations in India

By Mateen Dalal

Medtronic, a leading healthcare technology company, has announced plans to expand its R&D center in Hyderabad, India, with a whopping investment of USD 350 million. The existing facility is already the largest center for the company outside the U...

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

DuPont to buy Spectrum Plastics, anticipates high ROIC by fifth year

By Mateen Dalal

American chemical company DuPont de Nemours Inc. reportedly signed a definitive agreement to buy out Spectrum Plastics Group from AEA Investors, a U.S. based private equity firm. The acquisition will reinforce DuPont’s position in booming non-c...